PDPN is a prognostic biomarker and correlated with immune infiltrating in gastric cancer

Studies of PDPN in cancers have focused on the interactions with palates through the binding with CECL-2 which mainly express on palates and immune cells, while little is known on its interactions with immune cells. PDPN expression in cancers was analyzed through Oncomine, GEPIA, and TIMER database....

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Liya, Zhang, Peng, Sun, Wei, Zhou, Lei, Chu, Qian, Chen, Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220208/
https://www.ncbi.nlm.nih.gov/pubmed/32384443
http://dx.doi.org/10.1097/MD.0000000000019957

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220208/
https://www.ncbi.nlm.nih.gov/pubmed/32384443
http://dx.doi.org/10.1097/MD.0000000000019957

Ejemplares similares